10:56:42 EST Wed 23 Jan 2019
Enter Symbol
or Name

Login ID:
U S Securities and Exchange Commission
Symbol U : *SEC
Recent Sedar Documents

SEC charges Vancouver lawyer Dean for Biozoom

2018-05-15 16:40 ET - Street Wire

Also Street Wire (U-BIZM) Biozoom Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The U.S. Securities and Exchange Commission has filed civil fraud charges against Vancouver lawyer Faiyaz Dean and others for the manipulation of Biozoom Inc., a former OTC Bulletin Board listing. The SEC claims that the group made $34-million while boosting a purported skin health product. (All figures are in U.S. dollars.) Mr. Dean's role included hiding the fact that his co-defendants had large, illegally acquired share positions, the SEC says.

The allegations are contained in a civil complaint that the SEC filed in the Southern District of New York on Tuesday, May 15. The complaint identifies Mr. Dean, 40, as a lawyer licensed to practice in British Columbia and Washington State. (His law firm, Dean Law Corp., has offices in Vancouver and Seattle.) His co-defendants are Guillermo Ciupiak, 35, of Spain; Francisco Abellan Villena, 47, of Spain; and James Panther Jr., 45, of California.

The scheme, as described by the SEC, goes back to December, 2010, when Mr. Ciupiak contacted Mr. Dean looking to take a company public. The SEC says that Mr. Dean located a suitable shell, for which the men paid $430,000. According to the complaint, Mr. Dean structured the deal so that Mr. Abellan and Mr. Ciupiak controlled all of the shares of the resulting company, which became Biozoom. Through a series of fraudulent share purchase agreements, Mr. Dean arranged for some of the stock to be held in the names of Argentine nominees, the SEC says.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.